Amphastar Pharmaceuticals Cash from Financing (TTM) Analysis

Amphastar Pharmaceuticals Inc (AMPH)

42.19 -0.25 (-0.59%) USD | NASDAQ | May 10, 16:00

42.19 0.00 (0.00%) After-Hours: 18:41

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	454.09M
September 30, 2023	485.01M
June 30, 2023	384.47M
March 31, 2023	-44.64M
December 31, 2022	-26.44M
September 30, 2022	-18.97M
June 30, 2022	-21.53M
March 31, 2022	-25.73M
December 31, 2021	-37.02M
September 30, 2021	-28.55M
June 30, 2021	-15.08M
March 31, 2021	2.564M
December 31, 2020	-2.246M
September 30, 2020	-12.40M
June 30, 2020	-13.26M
March 31, 2020	-26.46M
December 31, 2019	-3.783M
September 30, 2019	23.52M
June 30, 2019	45.21M
March 31, 2019	47.06M
December 31, 2018	25.01M

Date	Value
September 30, 2018	7.284M
June 30, 2018	-16.03M
March 31, 2018	-6.828M
December 31, 2017	-7.718M
September 30, 2017	-8.177M
June 30, 2017	10.81M
March 31, 2017	2.455M
December 31, 2016	7.14M
September 30, 2016	2.83M
June 30, 2016	-14.36M
March 31, 2016	-9.241M
December 31, 2015	2.237M
September 30, 2015	-0.745M
June 30, 2015	1.504M
March 31, 2015	27.38M
December 31, 2014	32.12M
September 30, 2014	36.97M
June 30, 2014	38.80M
March 31, 2014	-9.732M
December 31, 2013	-9.37M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-44.64M

Minimum

Mar 2023

485.01M

Maximum

Sep 2023

58.88M

Average

-13.26M

Median

Jun 2020

Cash from Financing (TTM) Benchmarks